Our Board

Lung Cancer Europe is led by an Executive Board made up of the President, Vice-President, Treasurer and board members, all elected by the General Assembly. Board members serve voluntarily and are unpaid. The board sets our strategic direction and safeguards the organisation.

Debra Montague

President

Debra is the first President of Lung Cancer Europe with lived experience of lung cancer. For more than 25 years she worked in senior roles in the pharmaceutical industry, until a stage IV ALK-positive diagnosis in 2016 changed her path: she founded ALK Positive Lung Cancer UK, the leading charity for people with ALK+ in the UK, and joined the board of ALK Positive Europe. She was elected Vice-President of Lung Cancer Europe in 2023 and President in 2025.

Angeliki Souri

Angeliki Souri Lung Cancer Europe Vice President 
Vice President

Angeliki became Vice-President of Lung Cancer Europe in 2025, after joining the board in 2024. She built a 20-year career in communications and sales, and is a graduate of the National & Kapodistrian University of Athens in Political Science and Public Administration. She has been a lung cancer patient advocate since 2021 and a Member of the Advisory Committee of FairLife Lung Cancer Care, Greece’s first non-profit organisation dedicated to lung cancer, where she leads on content and communications.

Soumitra Böse

Treasurer

Soumitra became Treasurer of Lung Cancer Europe in April 2026, bringing financial stewardship and governance insight to the board. After a global career in finance and corporate governance, he has spent more than a decade as a trustee and treasurer of NGOs and community organisations. Diagnosed with stage 2 EGFR-positive lung cancer in 2021, he brings that lived experience to his work as a trustee of EGFR Positive Lung Cancer UK, focusing on awareness, support for people affected by lung cancer, and the governance that keeps a charity sustainable.

Merel Hennink

Board Member

Merel joined the board of Lung Cancer Europe in 2025, representing the Dutch organisation Longkanker Nederland. She moved from a career in programme management and teaching at Hanze University of Applied Sciences into full-time advocacy after a stage IV ROS1-positive diagnosis in 2014, founding Stichting Merels Wereld to raise awareness of ROS1 and drive research. That work helped launch a ROS1 research programme with Hanze University and University Hospital Groningen.

Nicoline Ehrhardt

Board Member

Nicoline joined the board of Lung Cancer Europe in 2025. She is a German Patient Advocate and board member of zielGENau e. V., the German Patient Network for Personalized Lung Cancer Therapy, dedicated to strengthening the patient voice in healthcare. She advocates for person-centred care, health literacy, and meaningful collaboration between people affected by lung cancer, healthcare professionals, researchers, and policymakers, with a strong focus on advancing research and innovation in lung cancer.


Strategy and direction

  • Set the strategic direction so Lung Cancer Europe delivers its vision and mission

  • Make sure the organisation is meeting its mission, objectives and purpose

  • Keep the organisation developing effectively and in line with its statutes

  • Decide which projects to take on and which congresses to attend, and follow them up


People and oversight

  • Oversee contractors so the organisation runs smoothly

    and projects land on time

  • Recruit, support and, where necessary, release staff

  • Monitor staff performance and the quality of their work

  • Appoint a board member to oversee staff against an agreed plan and report back

  • Maintain effective working practices, with a clear division of roles between board and staff

  • Ensure a suitable succession plan is in place


Legal and financial responsibility

  • Hold legal and financial responsibility, with systems in place to protect and grow the organisation

  • Put the right policies and practices in place for sound governance and administration

  • Secure and manage the funding the organisation needs

  • Review and approve the budget before the Annual General Meeting (AGM), and ensure funds are used as agreed

  • Keep accounts as required by law and good practice


Members and representation

  • Review and approve membership applications

  • Manage membership, including ending it, as set out in the Constitution

  • Act as ambassadors, representing Lung Cancer Europe rather than their home organisation

  • Promote and uphold the organisation's values: representativeness, commitment, reliability, trust and uniqueness

More on who we are